The DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.
The Design of Inhibitors for Medicinally Relevant Metalloproteins
Abstract
A number of metalloproteins are important medicinal targets for conditions ranging from pathogenic infections to cancer. Many but not all of these metalloproteins contain a zinc(II) ion in the protein active site. Small‐molecule inhibitors of these metalloproteins are designed to bind directly to the active site metal ions. In this review several metalloproteins of interest are discussed, including matrix metalloproteinases (MMPs), histone deacetylases (HDACs), anthrax lethal factor (LF), and others. Different strategies that have been employed to design effective inhibitors against these proteins are described, with an effort to highlight the strengths and drawbacks of each approach. An emphasis is placed on examining the bioinorganic chemistry of these metal active sites and how a better understanding of the coordination chemistry in these systems may lead to improved inhibitors. It is hoped that this review will help inspire medicinal, biological, and inorganic chemists to tackle this important problem by considering all aspects of metalloprotein inhibitor design.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In most cases, a drug molecule establishes coordination bonds with the zinc ion10 present in the protein”
From AutoDock4Zn: An Improved AutoDock Force Field for Small-Molecule Docking to Zinc Metalloproteins (2014) · cites this paper as [10]
Citations
Cites
Miller, M. B., & Bassler, B. L. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.165 · Cited by 5,105
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
How Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959
Structure and function of matrix metalloproteinases and TIMPs
NAGASE, H., VISSE, R., & MURPHY, G. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.12.002 · Cited by 3,409
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
Discovering High-Affinity Ligands for Proteins: SAR by NMR
Shuker, S. B., Hajduk, P. J., Meadows, R. P., & Fesik, S. W. (1996) · Science · doi:10.1126/science.274.5292.1531 · Cited by 2,041
Botulinum Toxin as a Biological Weapon: Medical and Public Health Management
Arnon, S. S., Schechter, R., Inglesby, T. V., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., Fine, A. D., Hauer, J., Layton, M., et al. (2001) · JAMA · doi:10.1001/jama.285.8.1059 · Cited by 1,814
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,554
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
Johnstone, R. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd772 · Cited by 1,515
Van Wart, H. E., & Birkedal-Hansen, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5578 · Cited by 1,475
Cardiac Hypertrophy: The Good, the Bad, and the Ugly
Frey, N., & Olson, E. N. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142243 · Cited by 1,449
Supuran, C. T., Scozzafava, A., & Casini, A. (2003) · Medicinal Research Reviews · doi:10.1002/med.10025 · Cited by 1,449
Inflammatory Cytokines and Postmyocardial Infarction Remodeling
Nian, M., Lee, P., Khaper, N., & Liu, P. (2004) · Circulation Research · doi:10.1161/01.res.0000130526.20854.fa · Cited by 1,028
Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors
Whittaker, M., Floyd, C. D., Brown, P., & Gearing, A. J. H. (1999) · Chemical Reviews · doi:10.1021/cr9804543 · Cited by 982
Ducharme, A., Frantz, S., Aikawa, M., Rabkin, E., Lindsey, M., Rohde, L. E., Schoen, F. J., Kelly, R. A., Werb, Z., Libby, P., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8768 · Cited by 808
Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy
Hidalgo, M., & Eckhardt, S. G. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.3.178 · Cited by 798
Blankenberg, S., Rupprecht, H. J., Poirier, O., Bickel, C., Smieja, M., Hafner, G., Meyer, J., Cambien, F., & Tiret, L. (2003) · Circulation · doi:10.1161/01.cir.0000058700.41738.12 · Cited by 755
Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases
Somoza, J. R., Skene, R. J., Katz, B. A., Mol, C., Ho, J. D., Jennings, A. J., Luong, C., Arvai, A., Buggy, J. J., Chi, E., et al. (2004) · Structure · doi:10.1016/j.str.2004.04.012 · Cited by 710
Tetracyclines Inhibit Connective Tissue Breakdown by Multiple Non-Antimicrobial Mechanisms
Golub, L. M., Lee, H.-M., Ryan, M. E., Giannobile, W. V., Payne, J., & Sorsa, T. (1998) · Advances in Dental Research · doi:10.1177/08959374980120010501 · Cited by 687
Interspecies communication in bacteria
Federle, M. J., & Bassler, B. L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320195 · Cited by 622
Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.
Gomis-R¨th, F.-X., Maskos, K., Betz, M., Bergner, A., Huber, R., Suzuki, K., Yoshida, N., Nagase, H., Brew, K., Bourenkov, G. P., et al. (1997) · Nature · doi:10.1038/37995 · Cited by 619
Zhang, B., Ye, S., Herrmann, S.-M., Eriksson, P., de Maat, M., Evans, A., Arveiler, D., Luc, G., Cambien, F., Hamsten, A., et al. (1999) · Circulation · doi:10.1161/01.cir.99.14.1788 · Cited by 611
Creemers, E. E. J. M., Cleutjens, J. P. M., Smits, J. F. M., & Daemen, M. J. A. P. (2001) · Circulation Research · doi:10.1161/hh1501.094396 · Cited by 598
Strickland, D. K., Ashcom, J. D., Williams, S., Burgess, W. H., Migliorini, M., & Argraves, W. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38172-9 · Cited by 558
Carbonic anhydrase inhibitors and their therapeutic potential
Supuran, C. T., & Scozzafava, A. (2000) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.10.5.575 · Cited by 549
Structure of Human Pro-Matrix Metalloproteinase-2: Activation Mechanism Revealed
Morgunova, E., Tuuttila, A., Bergmann, U., Isupov, M., Lindqvist, Y., Schneider, G., & Tryggvason, K. (1999) · Science · doi:10.1126/science.284.5420.1667 · Cited by 540
Grozinger, C. M., & Schreiber, S. L. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00092-3 · Cited by 537
Histone Deacetylase Inhibitors
Miller, T. A., Witter, D. J., & Belvedere, S. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0303094 · Cited by 530
Collier, R. J., & Young, J. A. T. (2003) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.19.111301.140655 · Cited by 511
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
Lehrman, G., Hogue, I. B., Palmer, S., Jennings, C., Spina, C. A., Wiegand, A., Landay, A. L., Coombs, R. W., Richman, D. D., Mellors, J. W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67098-5 · Cited by 510
Macrophage Apoptosis by Anthrax Lethal Factor Through p38 MAP Kinase Inhibition
Park, J. M., Greten, F. R., Li, Z.-W., & Karin, M. (2002) · Science · doi:10.1126/science.1073163 · Cited by 500
Carbonic anhydrase. Purification and nature of the enzyme
Keilin, D., & Mann, T. (1940) · Biochemical Journal · doi:10.1042/bj0341163 · Cited by 493
Brown, D. L., Hibbs, M. S., Kearney, M., Loushin, C., & Isner, J. M. (1995) · Circulation · doi:10.1161/01.cir.91.8.2125 · Cited by 487
Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice
Gough, P. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25074 · Cited by 452
Chia, S. K., Wykoff, C. C., Watson, P. H., Han, C., Leek, R. D., Pastorek, J., Gatter, K. C., Ratcliffe, P., & Harris, A. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3660 · Cited by 432
NF‐κB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation
Williams, S. A., Chen, L., Kwon, H., Ruiz‐Jarabo, C. M., Verdin, E., & Greene, W. C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600900 · Cited by 430
Loftus, I. M., Naylor, A. R., Goodall, S., Crowther, M., Jones, L., Bell, P. R. F., & Thompson, M. M. (2000) · Stroke · doi:10.1161/01.str.31.1.40 · Cited by 421
Biological Warfare: A Historical Perspective
Christopher, L. G. W. (1997) · JAMA · doi:10.1001/jama.1997.03550050074036 · Cited by 417
Suppression of Class I and II Histone Deacetylases Blunts Pressure-Overload Cardiac Hypertrophy
Kong, Y., Tannous, P., Lu, G., Berenji, K., Rothermel, B. A., Olson, E. N., & Hill, J. A. (2006) · Circulation · doi:10.1161/circulationaha.106.625467 · Cited by 377
Contribution of individual toxin components to virulence of Bacillus anthracis
Pezard, C., Berche, P., & Mock, M. (1991) · Infection and Immunity · doi:10.1128/iai.59.10.3472-3477.1991 · Cited by 368
A role for histone deacetylase activity in HDAC1-mediated transcriptional repression
Hassig, C. A., Tong, J. K., Fleischer, T. C., Owa, T., Grable, P. G., Ayer, D. E., & Schreiber, S. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3519 · Cited by 365
Coleman, J. E. (1998) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(98)80064-1 · Cited by 362
Bode, W., Reinemer, P., Huber, R., Kleine, T., Schnierer, S., & Tschesche, H. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06378.x · Cited by 339
Matsumura, S.-I., Iwanaga, S., Mochizuki, S., Okamoto, H., Ogawa, S., & Okada, Y. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522304 · Cited by 339
Spinale, F. G., Coker, M. L., Krombach, S. R., Mukherjee, R., Hallak, H., Houck, W. V., Clair, M. J., Kribbs, S. B., Johnson, L. L., Peterson, J. T., et al. (1999) · Circulation Research · doi:10.1161/01.res.85.4.364 · Cited by 323
Gueders, M. M., Foidart, J.-M., Noel, A., & Cataldo, D. D. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.082 · Cited by 322
Bacterial toxins: a table of lethal amounts.
Dm, G. (1982) · Microbiological Reviews · doi:10.1128/mmbr.46.1.86-94.1982 · Cited by 322
Fernandez‐Catalan, C., Bode, W., Huber, R., Turk, D., Calvete, J. J., Lichte, A., Tschesche, H., & Maskos, K. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5238 · Cited by 321
Zinc sensing for cellular application
Kikuchi, K., Komatsu, K., & Nagano, T. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.02.007 · Cited by 320
Discovery of Potent Nonpeptide Inhibitors of Stromelysin Using SAR by NMR
Hajduk, P. J., Sheppard, G., Nettesheim, D. G., Olejniczak, E. T., Shuker, S. B., Meadows, R. P., Steinman, D. H., Carrera, G. M., Marcotte, P. A., Severin, J., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja9702778 · Cited by 317
Barrett, A. J. (1981) · Methods in Enzymology · doi:10.1016/s0076-6879(81)80056-0 · Cited by 314
Illuminating Zinc in Biological Systems
Lim, N. C., Freake, H. C., & Brückner, C. (2005) · Chemistry – A European Journal · doi:10.1002/chem.200400599 · Cited by 311
Histone deacetylase inhibitors in cancer treatment
Vigushin, D. M., & Coombes, R. C. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200201000-00001 · Cited by 301
Swinson, D. E. B., Jones, J. L., Richardson, D., Wykoff, C., Turley, H., Pastorek, J., Taub, N., Harris, A. L., & O’Byrne, K. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.132 · Cited by 287
Crystal structures of matrilysin-inhibitor complexes
Browner, M. F., Smith, W. W., & Castelhano, A. L. (1995) · Biochemistry · doi:10.1021/bi00020a004 · Cited by 263
Applications of carbonic anhydrase inhibitors and activators in therapy
Supuran, C. T., & Scozzafava, A. (2002) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.12.2.217 · Cited by 258
Browner, M. F., Lovejoy, B., Welch, A. R., Carr, S., Luong, C., Broka, C. A., Hendricks, R. T., Campbell, J. A., Walker, K. A. M., Martin, R., et al. (1999) · Nature Structural Biology · doi:10.1038/6657 · Cited by 255
Mazel, D., Pochet, S., & Marlière, P. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06335.x · Cited by 246
Histone deacetylase inhibitors: Multifunctional anticancer agents
Liu, T., Kuljaca, S., Tee, A., & Marshall, G. M. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2005.12.006 · Cited by 230
Scozzafava, A., & Supuran, C. T. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000027t · Cited by 225
Myocardial Infarct Expansion and Matrix Metalloproteinase Inhibition
Mukherjee, R., Brinsa, T. A., Dowdy, K. B., Scott, A. A., Baskin, J. M., Deschamps, A. M., Lowry, A. S., Escobar, G. P., Lucas, D. G., Yarbrough, W. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000046449.36178.00 · Cited by 222
Rao, B. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053382115 · Cited by 221
Khokha, R. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.4.299 · Cited by 220
Morgunova, E., Tuuttila, A., Bergmann, U., & Tryggvason, K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102185399 · Cited by 219
Recent advances in MMP inhibitor design
Fisher, J. F., & Mobashery, S. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7894-9 · Cited by 215
Mautino, G., Oliver, N., Chanez, P., Bousquet, J., & Capony, F. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.17.5.2562 · Cited by 213
Skiles, J. W., Gonnella, N. C., & Jeng, A. Y. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043364018 · Cited by 209
Potent and Selective Mechanism-Based Inhibition of Gelatinases
Brown, S., Bernardo, M. M., Li, Z.-H., Kotra, L. P., Tanaka, Y., Fridman, R., & Mobashery, S. (2000) · Journal of the American Chemical Society · doi:10.1021/ja001461n · Cited by 197
PETERSON, J. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.11.032 · Cited by 196
The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor
Turk, B. E., Wong, T. Y., Schwarzenbacher, R., Jarrell, E. T., Leppla, S. H., Collier, R. J., Liddington, R. C., & Cantley, L. C. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb708 · Cited by 179
Bacterial Cell-to-Cell Signaling in the Gastrointestinal Tract
Kaper, J. B., & Sperandio, V. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3197-3209.2005 · Cited by 178
Matrix Metalloproteinase-8 Deficiency Promotes Granulocytic Allergen-Induced Airway Inflammation
Gueders, M. M., Balbin, M., Rocks, N., Foidart, J.-M., Gosset, P., Louis, R., Shapiro, S., Lopez-Otin, C., Noël, A., & Cataldo, D. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2589 · Cited by 158
McClerren, A. L., Endsley, S., Bowman, J. L., Andersen, N. H., Guan, Z., Rudolph, J., & Raetz, C. R. H. (2005) · Biochemistry · doi:10.1021/bi0518186 · Cited by 155
Role of matrix metalloproteinases in asthma
KELLY, E. A. B., & Jarjour, N. N. (2003) · Current Opinion in Pulmonary Medicine · doi:10.1097/00063198-200301000-00005 · Cited by 154
Gantt, S. L., Gattis, S. G., & Fierke, C. A. (2006) · Biochemistry · doi:10.1021/bi060212u · Cited by 151
Disruption of the Plasminogen Gene in Mice Abolishes Wound Healing after Myocardial Infarction
Creemers, E. E., Cleutjens, J. P. M., Smits, J. F. M., Heymans, S. R. B., Moons, L., Collen, D., Daemen, M. J. A. P., & Carmeliet, P. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65060-2 · Cited by 150
Puerta, D. T., Lewis, J. A., & Cohen, S. M. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0485513 · Cited by 148
Self-citationFujita, M., Nakao, Y., Matsunaga, S., Seiki, M., Itoh, Y., Yamashita, J. K., van Soest, R. W. M., & Fusetani, N. (2003) · Journal of the American Chemical Society · doi:10.1021/ja038025w · Cited by 146
Peptide Deformylase: A New Type of Mononuclear Iron Protein
Rajagopalan, P. T. R., Yu, X. C., & Pei, D. (1997) · Journal of the American Chemical Society · doi:10.1021/ja9734096 · Cited by 142
Ikonomidis, J. S., Hendrick, J. W., Parkhurst, A. M., Herron, A. R., Escobar, P. G., Dowdy, K. B., Stroud, R. E., Hapke, E., Zile, M. R., & Spinale, F. G. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00370.2004 · Cited by 137
Chemical screening by mass spectrometry to identify inhibitors of anthrax lethal factor
Min, D., Tang, W., & Mrksich, M. (2004) · Nature Biotechnology · doi:10.1038/nbt973 · Cited by 136
Identification of small molecule inhibitors of anthrax lethal factor
Panchal, R. G., Hermone, A. R., Nguyen, T. L., Wong, T. Y., Schwarzenbacher, R., Schmidt, J. J., Lane, D. J., McGrath, C. F., Turk, B. E., Burnett, J. C., et al. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsmb711 · Cited by 136
Gao, J., Cheng, X., Chen, R., Sigal, G. B., Bruce, J. E., Schwartz, B. L., Hofstadler, S. A., Anderson, G., Smith, R. D., & Whitesides, G. M. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960013g · Cited by 132
Prikk, K., Maisi, P. S., Pirilä, E., Reintam, M.-A., Salo, T. A., Sorsa, T. A., & Sepper, R. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000035023.53893.b6 · Cited by 131
Guilloteau, J. P., Mathieu, M., Giglione, C., Blanc, V., Dupuy, A., Chevrier, M., Gil, P., Famechon, A., Meinnel, T., & Mikol, V. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00549-1 · Cited by 130
Efficient synthetic inhibitors of anthrax lethal factor
Forino, M., Johnson, S. L., Wong, T. Y., Rozanov, D. V., Savinov, A. Y., Li, W., Fattorusso, R., Becattini, B., Orry, A. J. W., Jung, D., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502733102 · Cited by 128
Antimetastatic Activity of a Novel Mechanism-Based Gelatinase Inhibitor
Krüger, A., Arlt, M., Gerg, M., Kopitz, C., Bernardo, M. M., Chang, M., Mobashery, S., & Fridman, R. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3570 · Cited by 127
Virtual Screening against Metalloenzymes for Inhibitors and Substrates
Irwin, J. J., Raushel, F. M., & Shoichet, B. K. (2005) · Biochemistry · doi:10.1021/bi050801k · Cited by 127
Bacterial Peptide Deformylase Inhibitors: A New Class of Antibacterial Agents
Jain, R., Chen, D., White, R. L., Patel, D., & Yuan, Z. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867054367194 · Cited by 127
Structure of the LpxC deacetylase with a bound substrate-analog inhibitor
Coggins, B. E., Li, X., McClerren, A. L., Hindsgaul, O., Raetz, C. R. H., & Zhou, P. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb948 · Cited by 122
Suzuki, T., Nagano, Y., Kouketsu, A., Matsuura, A., Maruyama, S., Kurotaki, M., Nakagawa, H., & Miyata, N. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049207j · Cited by 121
Yarbrough, W. M., Mukherjee, R. D., Escobar, G. P., Mingoia, J. T., Sample, J. A., Hendrick, J. W., Dowdy, K. B., McLean, J. E., Lowry, A. S., O’Neill, T. P., et al. (2003) · Circulation · doi:10.1161/01.cir.0000091087.78630.79 · Cited by 120
X-ray Structure of Human proMMP-1
Jozic, D., Bourenkov, G. P., Lim, N. H., Visse, R., Nagase, H., Bode, W., & Maskos, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411084200 · Cited by 119
Cuniasse, P., Devel, L., Makaritis, A., Beau, F., Georgiadis, D., Matziari, M., Yiotakis, A., & Dive, V. (2004) · Biochimie · doi:10.1016/j.biochi.2004.09.025 · Cited by 117
Purification of human collagenases with a hydroxamic acid affinity column
Moore, W. M., & Spilburg, C. A. (1986) · Biochemistry · doi:10.1021/bi00366a031 · Cited by 114
Screening inhibitors of anthrax lethal factor
Tonello, F., Seveso, M., Marin, O., Mock, M., & Montecucco, C. (2002) · Nature · doi:10.1038/418386a · Cited by 113
Hu, X., & Shelver, W. H. (2003) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(03)00153-0 · Cited by 112
MMP Induction and Inhibition in Myocardial Infarction
Lindsey, M. L. (2004) · Heart Failure Reviews · doi:10.1023/b:hrev.0000011390.44039.b7 · Cited by 110
Examination of Novel Zinc-Binding Groups for Use in Matrix Metalloproteinase Inhibitors
Puerta, D. T., & Cohen, S. M. (2003) · Inorganic Chemistry · doi:10.1021/ic026029g · Cited by 109
Self-citationQuorum sensing: an emerging target for antibacterial chemotherapy?
Williams, P. M. (2002) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.6.3.257 · Cited by 108
Lang, R., Kocourek, A., Braun, M., Tschesche, H., Huber, R., Bode, W., & Maskos, K. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4954 · Cited by 107
Pöllänen, P. J., Karhunen, P. J., Mikkelsson, J., Laippala, P., Perola, M., Penttilä, A., Mattila, K. M., Koivula, T. A., & Lehtimäki, T. J. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0901.095545 · Cited by 105
Captopril: Pharmacology, Metabolism, and Disposition
Migdalof, B. H., Antonaccio, M. J., Kinstry, D. N. M., Singhvi, S. M., Lan, S.-J., Egli, P., & Kripalani, K. J. (1984) · Drug Metabolism Reviews · doi:10.3109/03602538409041080 · Cited by 103
Characterization of a Human Peptide Deformylase: Implications for Antibacterial Drug Design
Nguyen, K. T., Hu, X., Colton, C., Chakrabarti, R., Zhu, M. X., & Pei, D. (2003) · Biochemistry · doi:10.1021/bi0346446 · Cited by 99
Synthesis of LuxS Inhibitors Targeting Bacterial Cell−Cell Communication
Alfaro, J. F., Zhang, T., Wynn, D. P., Karschner, E. L., & Zhou, Z. S. (2004) · Organic Letters · doi:10.1021/ol049182i · Cited by 99
Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity
Burnett, J. C., Schmidt, J. J., Stafford, R. G., Panchal, R. G., Nguyen, T. L., Hermone, A. R., Vennerstrom, J. L., McGrath, C. F., Lane, D. J., Sausville, E. A., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.112 · Cited by 98
A practical approach to docking of zinc metalloproteinase inhibitors
Hu, X., Baláž, Š., & Shelver, W. H. (2004) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2003.11.002 · Cited by 97
A high‐affinity competitive inhibitor of type A botulinum neurotoxin protease activity
Schmidt, J. J., & Stafford, R. G. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03738-9 · Cited by 95
Design and Synthesis of Substrate and Intermediate Analogue Inhibitors of S-Ribosylhomocysteinase
Shen, G., Rajan, R., Zhu, J. G., Bell, C. E., & Pei, D. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060047g · Cited by 92
Matrix Metalloproteinases in Tissue Repair
Parks, W. C., Sudbeck, B. D., Doyle, G. R., & Saariahlo-Kere, U. K. (1998) · Elsevier eBooks · doi:10.1016/b978-012545090-4/50012-4 · Cited by 89
Schröder, J., Henke, A., Wenzel, H., Brandstetter, H., Stammler, H., Stammler, A., Pfeiffer, W. ‐., & Tschesche, H. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010887p · Cited by 88
Schmidt, J. J., Stafford, R. G., & Bostian, K. A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01041-2 · Cited by 87
Crystal Structures of Novel Non-peptidic, Non-zinc Chelating Inhibitors Bound to MMP-12
Morales, R., Perrier, S., Florent, J.-M., Beltra, J., Dufour, S., de Mendez, I., Manceau, P., Tertre, A., Moreau, F., Compère, D., et al. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.06.039 · Cited by 85
4-Alkylidene-azetidin-2-ones: novel inhibitors of leukocyte elastase and gelatinase
Cainelli, G., Galletti, P., Garbisa, S., Giacomini, D., Sartor, L., & Quintavalla, A. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.09.035 · Cited by 83
A New Role for Old Ligands: Discerning Chelators for Zinc Metalloproteinases
Jacobsen, F. E., Lewis, J. A., & Cohen, S. M. (2006) · Journal of the American Chemical Society · doi:10.1021/ja057957s · Cited by 82
Self-citationElucidating Drug-Metalloprotein Interactions with Tris(pyrazolyl)borate Model Complexes
Puerta, D. T., & Cohen, S. M. (2002) · Inorganic Chemistry · doi:10.1021/ic0204272 · Cited by 81
Self-citationO’Brien, E. C., Farkas, E., Gil, M.-J., Fitzgerald, D. J., Castineras, A., & Nolan, K. B. (2000) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(99)00245-7 · Cited by 81
Potent, Selective Pyrone-Based Inhibitors of Stromelysin-1
Puerta, D. T., Mongan, J., Tran, B. L., McCammon, J. A., & Cohen, S. M. (2005) · Journal of the American Chemical Society · doi:10.1021/ja054558o · Cited by 80
Self-citationMatter, H., Schwab, W. G., Barbier, D., Billen, G., Haase, B., Neises, B., Schudok, M., Thorwart, W., Schreuder, H., Brachvogel, V., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980631s · Cited by 78
Terp, G. E., Cruciani, G., Christensen, I. T., & Jørgensen, F. S. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0109053 · Cited by 78
Puerta, D. T., Griffin, M. O., Lewis, J. A., Romero‐Perez, D., Garcia, R. A., Villarreal, F. J., & Cohen, S. M. (2005) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-005-0053-x · Cited by 78
Self-citationJude, K. M., Banerjee, A. L., Haldar, M. K., Manokaran, S., Roy, B. C., Mallik, S., Srivastava, D. K., & Christianson, D. W. (2006) · Journal of the American Chemical Society · doi:10.1021/ja057257n · Cited by 76
Improved gelatinase a selectivity by novel zinc binding groups containing galardin derivatives
Augé, F., Hornebeck, W., Decarme, M., & Laronze, J. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00214-2 · Cited by 75
Recent non-hydroxamate matrix metalloproteinase inhibitors
Breuer, E., Frant, J., & Reich, R. (2005) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.15.3.253 · Cited by 74
Kleifeld, O., Kotra, L. P., Gervasi, D. C., Brown, S., Bernardo, M. M., Fridman, R. A., Mobashery, S., & Sagi, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011604200 · Cited by 74
Anthrax lethal toxin: a weapon of multisystem destruction
Agrawal, A., & Pulendran, B. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4251-4 · Cited by 73
Fridman, M., Белахов, В. В., Lee, L. V., Liang, F., Wong, C., & Baasov, T. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200462003 · Cited by 72
Quest for Selectivity in Inhibition of Matrix Metalloproteinases
Brown, S., Meroueh, S. O., Fridman, R. A., & Mobashery, S. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043387854 · Cited by 70
Cataldo, D. D., Munaut, C., Noël, A., Frankenne, F., Bartsch, P., Foidart, J., & Louis, R. E. (2001) · Allergy · doi:10.1034/j.1398-9995.2001.056002145.x · Cited by 69
A Bioinorganic Perspective on Matrix Metalloproteinase Inhibition
Puerta, D. T., & Cohen, S. M. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043387368 · Cited by 68
Self-citationFinzel, B. C., Baldwin, E. T., Bryant, G. L., Hess, G. F., Wilks, J. W., Trepod, C. M., Mott, J. E., MARSHALL, V. P., Petzold, G. L., Poorman, R. A., et al. (1998) · Protein Science · doi:10.1002/pro.5560071008 · Cited by 68
Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors
Callier‐Dublanchet, A., Ducrot, P., Andrianjara, C. R., O’Gara, M., Morales, R., Compère, D., Denis, A., Blais, S., Cluzeau, P., Courté, K., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.05.079 · Cited by 68
Moy, F. J., Haraki, K., Mobilio, D., Walker, G., Powers, R., Tabei, K., Tong, H., & Siegel, M. M. (2001) · Analytical Chemistry · doi:10.1021/ac0006270 · Cited by 66
Becker, D. P., Villamil, C. I., Barta, T. E., Bedell, L. J., Boehm, T. L., DeCrescenzo, G. A., Freskos, J. N., Getman, D. P., Hockerman, S. L., Heintz, R., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0500875 · Cited by 66
Rodriquez, M., Aquino, M., Bruno, I., Martino, G., Taddei, M., & Gomez‐Paloma, L. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776360905 · Cited by 65
Similarity of Binding Sites of Human Matrix Metalloproteinases
Lukáčová, V., Zhang, Y., Mackov, M., Baričič, P., Raha, S., Calvo, J. A., & Baláž, Š. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313474200 · Cited by 65
Tziakas, D. N., Chalikias, G. K., Parissis, J., Hatzinikolaou, E. I., Papadopoulos, E. D., Trιpsianis, G., Papadopoulou, E. G., Tentes, I. K., Karas, S. M., & CHATSERAS, D. (2003) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.05.013 · Cited by 64
In vivo characterization of hydroxamic acid inhibitors of 5-lipoxygenase
Summers, J. B., Gunn, B. P., Mazdiyasni, H., Goetze, A. M., Young, P. R., Bouska, J. B., Dyer, R. D., Brooks, D. W., & Carter, G. W. (1987) · Journal of Medicinal Chemistry · doi:10.1021/jm00394a032 · Cited by 64
Matter, H., Schudok, M., Schwab, W. G., Thorwart, W., Barbier, D., Billen, G., Haase, B., Neises, B., Weithmann, K. U., & Wollmann, T. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00215-8 · Cited by 63
Chen, L., Rydel, T. J., Gu, F., Dunaway, C. M., Pikul, S., Dunham, K. M., & Barnett, B. L. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3147 · Cited by 63
Squaric Acid-Based Peptidic Inhibitors of Matrix Metalloprotease-1
Onaran, M. B., Comeau, A. B., & Seto, C. T. (2005) · The Journal of Organic Chemistry · doi:10.1021/jo0517848 · Cited by 61
Light Chain of Botulinum Neurotoxin Serotype A: Structural Resolution of a Catalytic Intermediate,
Fu, Z., Chen, S., Baldwin, M. R., Boldt, G. E., Crawford, A., Janda, K. D., Barbieri, J. T., & Kim, J. P. (2006) · Biochemistry · doi:10.1021/bi060786z · Cited by 61
Pirard, B., & Matter, H. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050363f · Cited by 59
Shultz, C. S., Dreher, S. D., Ikemoto, N., Williams, J. M., Grabowski, E. J. J., Krska, S. W., Sun, Y., Dormer, P. G., & DiMichele, L. M. (2005) · Organic Letters · doi:10.1021/ol050869s · Cited by 59
Campestre, C., Agamennone, M., Tortorella, P., Preziuso, S., Biasone, A., GAVUZZO, E., Pochetti, G., Mazza, F., Hiller, O., Tschesche, H., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.09.057 · Cited by 58
NMR-Based Modification of Matrix Metalloproteinase Inhibitors with Improved Bioavailability
Hajduk, P. J., Shuker, S. B., Nettesheim, D. G., Craig, R., Augeri, D. J., Betebenner, D. A., Albert, D. H., Guo, Y. P., Meadows, R. P., Xu, L., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020160g · Cited by 57
Novel indolactam-based inhibitors of matrix metalloproteinases
Castelhano, A. L., Billedeau, R. J., Dewdney, N. J., Donnelly, S., Horne, S., Kurz, L. J., Liak, T. J., Martin, R. L., Uppington, R., Yuan, Z., et al. (1995) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00233-j · Cited by 56
Balakrishnan, A., Patel, B., Sieber, S. A., Chen, D., Pachikara, N. D., Zhong, G., Cravatt, B. F., & Fan, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513648200 · Cited by 55
In vitro antibacterial activity of the peptide deformylase inhibitor BB-83698
Lofland, D. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh129 · Cited by 54
Mechanistic Inferences from the Binding of Ligands to LpxC, a Metal-Dependent Deacetylase,
Gennadios, H. A., Whittington, D. A., Li, X., Fierke, C. A., & Christianson, D. W. (2006) · Biochemistry · doi:10.1021/bi060823m · Cited by 52
Biaryl Ether Retrohydroxamates as Potent, Long-lived, Orally Bioavailable MMP Inhibitors
Michaelides, M. R., Dellaria, J. F., Gong, J., Holms, J. H., Bouska, J. J., Stacey, J. R., Wada, C. K., Heyman, H. R., Curtin, M. L., Guo, Y. P., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00031-2 · Cited by 51
Boldt, G. E., Eubanks, L. M., & Janda, K. D. (2006) · Chemical Communications · doi:10.1039/b603099h · Cited by 51
Kaden, J. J., Dempfle, C.-E. H., Sueselbeck, T., Brueckmann, M., Poerner, T. C., Haghi, D., Haase, K. K., & Borggrefe, M. (2003) · Cardiology · doi:10.1159/000070670 · Cited by 49
Yuan, Z., & White, R. J. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.015 · Cited by 48
Farkas, E., Katz, Y., Bhusare, S. R., Reich, R., Röschenthaler, G., Königsmann, M., & Breuer, E. (2004) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-004-0524-5 · Cited by 48
Using Model Complexes To Augment and Advance Metalloproteinase Inhibitor Design
Jacobsen, F. E., & Cohen, S. M. (2004) · Inorganic Chemistry · doi:10.1021/ic035388o · Cited by 45
Self-citationRecent progress in the development of assays suited for histone deacetylase inhibitor screening
Wegener, D., Hildmann, C., & Schwienhorst, A. (2003) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.08.008 · Cited by 41
Ménard, A., Papini, E., Mock, M., & Montecucco, C. (1996) · Biochemical Journal · doi:10.1042/bj3200687 · Cited by 41
Inhibition of the Proteolytic Activity of Anthrax Lethal Factor by Aminoglycosides
Lee, L. V., Bower, K. E., Liang, F., Shi, J., Wu, D., Sucheck, S. J., Vogt, P. K., & Wong, C. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0495359 · Cited by 40
The Medicinal Chemistry of Botulinum, Ricin and Anthrax Toxins
Hicks, R. P., Hartell, M. G., Nichols, D., Bhattacharjee, A. K., van Hamont, J. E., & Skillman, D. R. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053202223 · Cited by 39
Wainwright, C. L. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.01.001 · Cited by 36
Evaluation and Binding‐Mode Prediction of Thiopyrone‐Based Inhibitors of Anthrax Lethal Factor
Lewis, J. A., Mongan, J., McCammon, J. A., & Cohen, S. M. (2006) · ChemMedChem · doi:10.1002/cmdc.200600102 · Cited by 36
Self-citationNuma, M. M. D., Lee, L. V., Hsu, C., Bower, K. E., & Wong, C. (2005) · ChemBioChem · doi:10.1002/cbic.200500009 · Cited by 35
Singh, J., Conzentino, P., Cundy, K. C., Gainor, J. A., Gilliam, C. L., Gordon, T. D., Johnson, J. A., Morgan, B. A., Schneider, E. D., Wahl, R. C., et al. (1995) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00031-n · Cited by 32
Tegoni, M., Dallavalle, F., & Santos, M. A. (2003) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2003.10.010 · Cited by 31
Spinale, F. G., Escobar, G. P., Hendrick, J. W., Clark, L. L., Camens, S. S., Mingoia, J. T., Squires, C. G., Stroud, R. E., & Ikonomidis, J. S. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104455 · Cited by 31
Structure–activity relationships by mass spectrometry: identification of novel MMP-3 inhibitors
Ockey, D. A., Dotson, J., Struble, M. E., Stults, J. T., Bourell, J. H., Clark, K., & Gadek, T. R. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.10.053 · Cited by 30
Matrix metalloproteinases and their inhibitors in non-neoplastic otorhinolaryngological disease
De, S., Fenton, J. E., & Jones, A. S. (2005) · The Journal of Laryngology & Otology · doi:10.1258/0022215054273269 · Cited by 28
Reich, R., Katz, Y., Hadar, R., & Breuer, E. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1985 · Cited by 28
Bradham, W. S., Gunasinghe, H. R., Holder, J. R., Multani, M. M., Killip, D., Anderson, M., Meyer, D., Spencer, W. H., Torre‐Amione, G., & Spinale, F. G. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02595-0 · Cited by 24
Effect of microbial siderophores on matrix metalloproteinase‐2 activity
Gendron, R., Grenier, D., Sorsa, T. A., Uitto, V. J., & Mayrand, D. (1999) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.1999.tb02221.x · Cited by 14
Inhibition of matrix metalloproteinase-2 activity by siderophores of Pseudomonas species
Shinozaki, Y., Akutsu-Shigeno, Y., Nakajima‐Kambe, T., Inomata, S., Nomura, N., Nakahara, T., & Uchiyama, H. (2004) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-003-1521-2 · Cited by 13
Design and Synthesis of Sulfur Based Inhibitors of Matrix Metalloproteinase-1.
Fujisawa, T., Odake, S., Ogawa, Y., Yasuda, J., Morita, Y., & Morikawa, T. (2002) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.50.239 · Cited by 13
Fridman, M., Белахов, В. В., Lee, L. V., Liang, F., Wong, C., & Baasov, T. (2004) · Angewandte Chemie · doi:10.1002/ange.200462003 · Cited by 11
Research works printed but not linked: 12
- Rybacki J. J., 2005, The essential guide to prescription drugs
- Stetler‐Stevenson W. G., 1996, Am. J. Pathol., 148, 1345
- Montgomery A. M., 1994, Cancer Res., 54, 5467
- Reich R., 1988, Cancer Res., 48, 3307
- Jong G. P., 2006, Chin. J. Physiol., 49, 104
- 10.1172/JCI22304 · doi:10.1172/jci22304 · Paper page
- Cataldo D. D., 2003, Cell. Mol. Biol., 49, 875
- Matter H., 2004, Curr. Opin. Drug Discovery Dev., 7, 513
- Parkkila S., 2000, The carbonic anhydrases: new horizons
- Liao S. Y., 1994, Am. J. Pathol., 145, 598
- Lewis C., 2002, FDA Consum., 36, 11
- 10.1172/JCI20195 · doi:10.1172/jci20195 · Paper page
Cited by
Application of Metal Coordination Chemistry To Explore and Manipulate Cell Biology
Haas, K. L., & Franz, K. J. (2009) · Chemical Reviews · doi:10.1021/cr900134a · Cited by 984
Prodrug Strategies in Anticancer Chemotherapy
Kratz, F., Müller, I. A., Ryppa, C., & Warnecke, A. (2008) · ChemMedChem · doi:10.1002/cmdc.200700159 · Cited by 486
AutoDock4Zn: An Improved AutoDock Force Field for Small-Molecule Docking to Zinc Metalloproteins
Santos-Martins, D., Forli, S., Ramos, M. J., & Olson, A. J. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500209e · Cited by 318
MMPs as therapeutic targets—Still a viable option?
FINGLETON, B. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2007.06.006 · Cited by 279
Dormán, G., Cseh, S., Hajdú, I., Barna, L., Kónya, D., Kupai, K., Kovács, L., & Ferdinandy, P. (2010) · Drugs · doi:10.2165/11318390-000000000-00000 · Cited by 178
“As a viable solution, a combined approach was developed([20]) that carries out the fragment screening by ESI-MS first and then runs the NMR of the hits to identify the mode of action and major interactions.”
Metadata
- Authors
- Jacobsen, F. E., Lewis, J. A., & Cohen, S. M.
- Affiliations
- University of California San Diego (US)
- Venue
- ChemMedChem
- Publisher
- Wiley
- Published
- 2007-01-30
- Volume
- 2
- Issue
- 2
- Pages
- 152-171
- ISSN
- 1860-7179 (ISSN-L)
- 1860-7187
- OpenAlex
- W2102128466
- Cited by
- 132
- References
- 175
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 4 · 2021: 5 · 2020: 3 · 2019: 2 · 2018: 5 · 2017: 9 · 2016: 6 · 2015: 11 · 2014: 7 · 2013: 8 · 2012: 15
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- ChemMedChem (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Enzyme function and inhibition
- Keywords
- small molecule inhibitors, matrix metalloproteinases, histone deacetylase, anthrax lethal factor, bioinorganic chemistry, coordination chemistry
- MeSH terms
- Animals, Binding Sites, Catalysis, Cells, Cultured, Fibroblasts, Humans, Metalloproteins, Protease Inhibitors, Protein Conformation, Spectrum Analysis, Structure-Activity Relationship, Zinc, Drug Design, Inhibitory Concentration 50, Matrix Metalloproteinases, Myoblasts, Cardiac, Matrix Metalloproteinase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.